{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:05:19Z","timestamp":1789743919328,"version":"4.0.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bulcan.2026.05.007","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:27:45Z","timestamp":1785410865000},"page":"1109-1117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Qui r\u00e9f\u00e8rent les patients atteints de my\u00e9lome multiple en h\u00e9matologie-oncologie\u00a0: une \u00e9tude r\u00e9trospective \u00e0 l\u2019H\u00f4tel-Dieu de France"],"prefix":"10.1016","volume":"113","author":[{"given":"Georgy","family":"Kattan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi El","family":"Karak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad","family":"Wakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maissa","family":"Safieddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Zakhour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2026.05.007_bib0090","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2014-11-568881","article-title":"Pathogenesis beyond the cancer clone(s) in multiple myeloma","volume":"125","author":"Bianchi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0095","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0100","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival, a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0105","unstructured":"Myeloma\u00a0\u2013\u00a0Cancer Stat Facts. SEER n.d. https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html (accessed July 20, 2024)."},{"key":"10.1016\/j.bulcan.2026.05.007_bib0110","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(14)60493-1","article-title":"Multiple myeloma","volume":"385","author":"R\u00f6llig","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/ejh.12533","article-title":"Plasma cell leukemia: from biology to treatment","volume":"95","author":"Jelinek","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0125","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ajh.25117","article-title":"Multiple myeloma: 2018\u00a0update on diagnosis, risk-stratification, and management","volume":"93","author":"Rajkumar","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0130","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027\u00a0patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0140","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/10428190902741471","article-title":"Diagnostic delay and complications for older adults with multiple myeloma","volume":"50","author":"Friese","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.26900\/hsq.2605","article-title":"Evaluation of current survival and prognostic factors in multiple myeloma: Staging ISS or R-ISS?","volume":"5","author":"Pekta\u015f","year":"2025","journal-title":"Health Sci Q"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0150","first-page":"100252","article-title":"Lebanese real-world experience in treating multiple myeloma: a multicenter retrospective study","volume":"15","author":"Nasr","year":"2021","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0155","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood.V126.23.2115.2115","article-title":"The association of international staging system (ISS) stage with disease and symptom burden in patients with newly diagnosed multiple myeloma","volume":"126","author":"Fiala","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s44228-022-00017-3","article-title":"Management of multiple myeloma in the Middle East: unmet needs, challenges and perspective","volume":"4","author":"Ibrahim","year":"2022","journal-title":"Clin Hematol Int"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bjh.18025","article-title":"Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995\u00a0to 2019","volume":"197","author":"Swan","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2026.05.007_bib0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2204925","article-title":"Triplet therapy, transplantation, and maintenance until progression in myeloma","volume":"387","author":"Richardson","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126003243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126003243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:17:58Z","timestamp":1789741078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126003243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0007455126003243"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.05.007","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qui r\u00e9f\u00e8rent les patients atteints de my\u00e9lome multiple en h\u00e9matologie-oncologie\u00a0: une \u00e9tude r\u00e9trospective \u00e0 l\u2019H\u00f4tel-Dieu de France","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}